Also in this playlist...
This transcript is automatically generated
I'm Robert -- with your Fox Business brief investor disappointment with the European central bank's failure to take action is weighing on stocks here.
Investors that look for fresh measures to ease Europe's debt crisis after some strong words by ECB president just last week.
Shares of Bristol-Myers Squibb are plunging after the company suspended the study of a drug intended to treat the liver disease hepatitis seen.
A patient suffered heart failure which is raising concerns about that drug's potential and two and a half billion dollars Bristol paid by the company that developed.
And the securities exchange commission has also charged an executive at Bristol-Myers.
With insider trading.
The agency says the -- -- -- confidential information.
About companies being targeted for potential acquisitions and it bought options in those companies.
That is the latest from the Fox Business Network TV muted and how part of.
Filter by section